PMC:7317273 / 16165-16328
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T111 | 75-88 | Body_part | denotes | immune system | http://purl.org/sig/ont/fma/fma9825 |
| T112 | 116-121 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
| T113 | 136-141 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
| T114 | 154-162 | Body_part | denotes | NK cells | http://purl.org/sig/ont/fma/fma63147 |
| T115 | 157-162 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T32 | 75-88 | Body_part | denotes | immune system | http://purl.obolibrary.org/obo/UBERON_0002405 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T180 | 57-67 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activation |
| T181 | 75-88 | http://purl.obolibrary.org/obo/UBERON_0002405 | denotes | immune system |
| T182 | 109-112 | http://purl.obolibrary.org/obo/PR_000001004 | denotes | CD4 |
| T183 | 114-121 | http://purl.obolibrary.org/obo/CL_0000084 | denotes | T cells |
| T184 | 129-132 | http://purl.obolibrary.org/obo/CLO_0053438 | denotes | CD8 |
| T185 | 134-141 | http://purl.obolibrary.org/obo/CL_0000084 | denotes | T cells |
| T186 | 154-162 | http://purl.obolibrary.org/obo/CL_0000623 | denotes | NK cells |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 276 | 103-108 | Gene | denotes | CXCR3 | Gene:2833 |
| 277 | 109-112 | Gene | denotes | CD4 | Gene:920 |
| 278 | 123-128 | Gene | denotes | CXCR3 | Gene:2833 |
| 279 | 129-132 | Gene | denotes | CD8 | Gene:925 |
| 280 | 147-152 | Gene | denotes | CXCR3 | Gene:2833 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T299 | 0-163 | Sentence | denotes | After 6 days of infusion, the therapy inhibited the over-activation of the immune system by inhibiting CXCR3+CD4+ T cells, CXCR3+CD8+ T cells, and CXCR3+ NK cells. |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T278 | 68-70 | GO:0042116 | denotes | of |
| T279 | 75-88 | UBERON:0002405 | denotes | immune system |
| T280 | 103-108 | PR:000001207 | denotes | CXCR3 |
| T281 | 109-112 | PR:000001004 | denotes | CD4 |
| T282 | 114-121 | CL:0000084 | denotes | T cells |
| T283 | 123-128 | PR:000001207 | denotes | CXCR3 |
| T284 | 134-141 | CL:0000084 | denotes | T cells |
| T285 | 147-152 | PR:000001207 | denotes | CXCR3 |